| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $109.4M | $92.1M | $71.5M |
| YoY Revenue Growth % | +18.8% | +28.8% | — |
| Gross Profit | $73.6M | $59.4M | — |
| Gross Margin % | 67.3% | 64.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $11.7M | -$13.7M | -$26.4M |
| Operating Margin % | 10.7% | -14.9% | -36.9% |
| Net Income (GAAP) | $5.1M | -$20.1M | -$17.6M |
| EBITDA (Normalized) | $11.7M | -$13.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.7M | $4.9M | -$7.2M |
| Capital Expenditures (CapEx) | $58.0K | $112.0K | — |
| Free Cash Flow (FCF) | $18.7M | $4.8M | -$7.2M |
| FCF Margin % | 17.0% | 5.2% | -10.1% |
| Return on Invested Capital (ROIC %) | 7.3% | -8.1% | — |
| Cash & Short-Term Equivalents | $23.4M | $13.4M | — |
| Total Debt (Short + Long Term) | $21.4M | $30.8M | — |
| Total Stockholders' Equity | $128.3M | $117.0M | — |